HEART SURGERY FORUM, vol.18, no.3, 2015 (SCI-Expanded)
Background: The risk of reoperation due to bleeding after open heart surgery is 2.2%-4.2%. Extracorporeal circulation and emergency operations are the important risk factors. In coronary artery bypass graft (CABG) patients who are treated preoperatively with antiplatelets plus clopidogrel are the sources of postoperative bleeding. The aim of this study was to research the effect of local Ankaferd blood stopper (ABS) to prevent mediastinal bleeding in on-pump CABG patients who were treated with clopidogrel and acetylsalicylic acid (ASA) preoperatively.